CAMBRIAN BIOPHARMA INC sold 11.7% of their position (21.30K shares) of SENSEI BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $232.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 12/8/2025ACC: 0000897069-25-001776
10% Owner
Since Feb 2021
-21.30K
Net shares
Net seller
$232.7K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
21.30K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−5K
Price / share
$9.06
Trade value
$45.30K
% of position
2.7%
12/4/2025
182.65K→177.65K
Common Stock
Direct
Shares
−14.51K
Price / share
$11.40
Trade value
$165.39K
% of position
8.2%
12/5/2025
177.65K→163.15K
Common Stock
Direct
Shares
−1.75K
Price / share
$12.29
Trade value
$21.45K
% of position
1.1%
12/5/2025
163.15K→161.40K
Common Stock
Direct
Shares
−42.00
Price / share
$13.16
Trade value
$552.72
% of position
0.0%
12/5/2025
161.40K→161.36K
Total
Net shares
−21.30K
Net value
-$232.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/4/2025 | S · Sale | −5K | $9.06 | $45.30K | 2.7% | 182.65K | 177.65K |
| Common Stock Direct | 12/5/2025 | S · Sale | −14.51K | $11.40 | $165.39K | 8.2% | 177.65K | 163.15K |
| Common Stock Direct | 12/5/2025 | S · Sale | −1.75K | $12.29 | $21.45K | 1.1% | 163.15K | 161.40K |
| Common Stock Direct | 12/5/2025 | S · Sale | −42.00 | $13.16 | $552.72 | 0.0% | 161.40K | 161.36K |
| Total | −21.30K | -$232.69K | ||||||
Derivative Transactions0
No derivative transactions reported